bicalutamide has been researched along with Cell Transformation, Neoplastic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bouamar, H; Gu, X; Houghton, PJ; Qin, T; Sun, LZ; Wang, B; Wang, Y; Xia, L; Yang, J; Zeballos, C; Zhang, W; Zhou, Y; Zhu, H | 1 |
| Bai, VU; Barrack, ER; Hou, Z; Kim, SH; Menon, M; Murthy, S; Reddy, GP; Wu, M | 1 |
| Chang, YL; Chiu, WJ; Hsu, YK; Huang, CM; Luo, FJ; Weng, CF; Wu, TF; Yuan, TC | 1 |
| Heer, R | 1 |
| Cardi, A; Dattilo, C; Di Monaco, F; Di Silverio, F; Mariotti, G; Sciarra, A | 1 |
| Bryant, RJ; Cross, NA; Cunliffe, VT; Eaton, CL; Hamdy, FC | 1 |
| Heer, R; Leung, HY; Robson, CN; Shenton, BK | 1 |
1 review(s) available for bicalutamide and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma.
Topics: Adenocarcinoma; Adult; Androgen Antagonists; Anilides; Antineoplastic Agents; Cell Transformation, Neoplastic; Humans; Immunohistochemistry; Male; Middle Aged; Neuroendocrine Tumors; Nitriles; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 2006 |
6 other study(ies) available for bicalutamide and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Gli2 mediates the development of castration‑resistant prostate cancer.
Topics: Androgen Antagonists; Anilides; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Male; Mice; Nitriles; Nuclear Proteins; Prostatic Neoplasms, Castration-Resistant; RNA, Small Interfering; Tosyl Compounds; Xenograft Model Antitumor Assays; Zinc Finger Protein Gli2 | 2020 |
Role of androgen receptor in progression of LNCaP prostate cancer cells from G1 to S phase.
Topics: Androgen Receptor Antagonists; Anilides; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cyclin A; Cyclin E; DNA Replication; G1 Phase Cell Cycle Checkpoints; Humans; Male; Nitriles; Nuclear Proteins; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds | 2013 |
The oncogenic role of androgen receptors in promoting the growth of oral squamous cell carcinoma cells.
Topics: Androgen Antagonists; Androgens; Anilides; Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cyclin D1; Dihydrotestosterone; Gene Knockdown Techniques; Humans; Mice; Mouth Neoplasms; Nitriles; Precancerous Conditions; Receptors, Androgen; Tosyl Compounds | 2015 |
Hunterian Lecture. Characterisation of human prostate epithelial progenitor differentiation in response to androgens.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Antigens, Differentiation; Biomarkers, Tumor; Cell Transformation, Neoplastic; Cysteine Proteinase Inhibitors; Epithelial Cells; Humans; Leupeptins; Male; Metribolone; Middle Aged; Neoplastic Stem Cells; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Testosterone Congeners; Tosyl Compounds | 2011 |
EZH2 promotes proliferation and invasiveness of prostate cancer cells.
Topics: Androgen Antagonists; Anilides; Cell Growth Processes; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Histocytochemistry; Humans; Male; Neoplasms, Hormone-Dependent; Nitriles; Polycomb Repressive Complex 2; Prostatic Neoplasms; RNA, Small Interfering; Tosyl Compounds; Transcription Factors; Transcription, Genetic; Transfection | 2007 |
The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population.
Topics: AC133 Antigen; Acid Phosphatase; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antigens, CD; Cell Differentiation; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Epithelial Cells; Fibroblast Growth Factor 7; Glycoproteins; Humans; Integrin alpha2beta1; Keratin-18; Leupeptins; Male; Metribolone; Middle Aged; Neoplastic Stem Cells; Nitriles; Peptides; Phenotype; Prostate-Specific Antigen; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Tyrosine Phosphatases; Receptors, Androgen; RNA, Messenger; Signal Transduction; Testosterone Congeners; Tosyl Compounds | 2007 |